Unknown

Dataset Information

0

Novel three-dimensional cultures provide insights into thyroid cancer behavior.


ABSTRACT: Thyroid cancer has the fastest growing incidence of any cancer in the United States, as measured by the number of new cases per year. Despite advances in tissue culture techniques, a robust model for thyroid cancer spheroid culture is yet to be developed. Using eight established thyroid cancer cell lines, we created an efficient and cost-effective 3D culture system that can enhance our understanding of in vivo treatment response. We found that all eight cell lines readily form spheroids in culture with unique morphology, size, and cytoskeletal organization. In addition, we developed a high-throughput workflow that allows for drug screening of spheroids. Using this approach, we found that spheroids from K1 and TPC1 cells demonstrate significant differences in their sensitivities to dabrafenib treatment that closely model expected patient drug response. In addition, K1 spheroids have increased sensitivity to dabrafenib when compared to monolayer K1 cultures. Utilizing traditional 2D cultures of these cell lines, we evaluated the mechanisms of this drug response, showing dramatic and acute changes in their actin cytoskeleton as well as inhibition of migratory behavior in response to dabrafenib treatment. Our study is the first to describe the development of a robust spheroid system from established cultured thyroid cancer cell lines and adaptation to a high-throughput format. We show that combining 3D culture with traditional 2D methods provides a complementary and powerful approach to uncover drug sensitivity and mechanisms of inhibition in thyroid cancer.

SUBMITTER: Lee MA 

PROVIDER: S-EPMC7295136 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5854348 | BioStudies
2014-01-01 | S-EPMC3956916 | BioStudies
2018-01-01 | S-EPMC5951939 | BioStudies
2014-01-01 | S-EPMC4159185 | BioStudies
2020-01-01 | S-EPMC7352930 | BioStudies
2018-01-01 | S-EPMC6113177 | BioStudies
2020-01-01 | S-EPMC7774933 | BioStudies
2019-01-01 | S-EPMC6425026 | BioStudies
1000-01-01 | S-EPMC4556086 | BioStudies
1000-01-01 | S-EPMC6249215 | BioStudies